INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo CELLUVISC Eye Drops
SCHEDULING STATUS:
Schedule 0

PROPRIETARY NAME
(and dosage form):

CELLUVISC Eye Drops

COMPOSITION
CELLUVISC is an isotonic formulation and contains carboxymethylcellulose sodium 10 mg/mL, sodium chloride, sodium lactate, potassium chloride, calcium chloride dihydrate and purified water.

PHARMACOLOGICAL CLASSIFICATION
A 15.4 Ophthalmic preparations. Other.

PHARMACOLOGICAL ACTION
CELLUVISCis an isotonic, lubricating, non-preserved formulation similar to normal tears.

INDICATIONS
CELLUVISCEye Drops are indicated as a lubricant to relieve irritation and discomfort due to dryness of the eye or due to exposure to wind or sun.

CONTRA-INDICATIONS
Hypersensitivity to any of the ingredients.

WARNINGS
If irritation increases or persists for more than 24 hours, discontinue use and consult a medical practitioner.

DOSAGE AND DIRECTIONS FOR USE
Ensure that the container is intact before use. To open, twist off the tab. To avoid contamination, do not touch the tip of the container to any surface. Apply one or two drops in each eye as needed, or as directed. There is no special dosage schedule for the elderly or for children. Use immediately after opening. Do not store opened container. Discard after use.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS
Irritation on instillation is the most frequently reported side-effect. Transient blurring may also be experienced.

IDENTIFICATION
Clear, colourless to very slightly yellow solution in low density polyethylene single-use containers.

PRESENTATION
Cardboard cartons containing 30 single-use containers per carton.

STORAGE INSTRUCTIONS
Store unopened container in a cool place (below 25°C). Do not store opened single-use container. Discard after use. KEEP OUT OF REACH OF CHILDREN.

REGISTRATION NUMBER.
30/15.4/0144

NAME AND BUSINESS ADDRESS OF THE APPLICANT
Allergan Pharmaceuticals (Pty.) Ltd
Mount Royal Industrial Park,
James Crescent,
Halfway House.
Johannesburg
South Africa

DATE OF PUBLICATION OF THIS PACKAGE INSERT
28 June 1996

New addition to this site: November 2006
Source: Pharmaceutical Industry

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2006